Form D — Gasami Therapeutics, Inc.
0002104347-26-000001 · filed 2026-01-12
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $250,000
- Total sold
- $20,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Gasami Therapeutics, Inc.
- CIK
- 2104347
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2025
- Address
- 8401 MAYLAND DR
RICHMOND, VA 23294 - Phone
- 4342821615
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Sarah Hunter-Chang · Executive OfficerCharlotte, NC Find on LinkedIn ↗
View original on SEC EDGAR.